• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Risk Factors for Death from Influenza A(H1N1)pdm09, State of S?o Paulo, Brazil, 2009

tetano

Editor, Senior Moderator
PLoS One. 2015 Mar 16;10(3):e0118772. doi: 10.1371/journal.pone.0118772. eCollection 2015.
[h=1]Risk Factors for Death from Influenza A(H1N1)pdm09, State of S?o Paulo, Brazil, 2009.[/h] Ribeiro AF[SUP]1[/SUP], Pellini AC[SUP]2[/SUP], Kitagawa BY[SUP]2[/SUP], Marques D[SUP]2[/SUP], Madalosso G[SUP]2[/SUP], de Cassia Nogueira Figueira G[SUP]2[/SUP], Fred J[SUP]2[/SUP], Albernaz RK[SUP]2[/SUP], Carvalhanas TR[SUP]2[/SUP], Zanetta DM[SUP]3[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] This case-control study aimed to assess the risk factors for death from influenza A(H1N1)pdm09 in patients with laboratory confirmation, who had severe acute respiratory illness-SARI and were hospitalized between June 28th and August 29th 2009, in the metropolitan regions of S?o Paulo and Campinas, Brazil. Medical charts of all the 193 patients who died (cases) and the 386 randomly selected patients who recovered (controls) were investigated in 177 hospitals. Household interviews were conducted with those who had survived and the closest relative of those who had died. 73.6% of cases and 38.1% of controls were at risk of developing influenza-related complications. The 18-to-59-year age group (OR = 2.31, 95%CI: 1.31-4.10 (reference up to 18 years of age)), presence of risk conditions for severity of influenza (OR = 1.99, 95%CI: 1.11-3.57, if one or OR = 6.05, 95%CI: 2.76-13.28, if more than one), obesity (OR = 2.73, 95%CI: 1.28-5.83), immunosuppression (OR = 3.43, 95%CI: 1.28-9.19), and search for previous care associated with the hospitalization (OR = 3.35, 95%CI: 1.75-6.40) were risk factors for death. Antiviral treatment performed within 72 hours of the onset of symptoms (OR = 0.17, 95%CI: 0.08-0.37, if within 48hours, and OR = 0.30, 95%CI: 0.11-0.81, if between 48 and 72 hours) was protective against death. The identification of high-risk patients and early treatment are important factors for reducing morbi-mortality from influenza.


PMID: 25774804 [PubMed - in process]
 
Back
Top Bottom